US 12,065,420 B2
Uses of balaenone and method of extraction thereof
Peter Thomas Northcote, Lower Hutt (NZ); and Ameet Jonathan Singh, Lower Hutt (NZ)
Assigned to HARDIE HEALTH LIMITED, Wellington (NZ)
Appl. No. 17/270,767
Filed by HARDIE HEALTH LIMITED, Wellington (NZ)
PCT Filed Aug. 28, 2019, PCT No. PCT/IB2019/057224
§ 371(c)(1), (2) Date Feb. 23, 2021,
PCT Pub. No. WO2020/044245, PCT Pub. Date Mar. 5, 2020.
Claims priority of application No. 745822 (NZ), filed on Aug. 29, 2018.
Prior Publication US 2021/0332023 A1, Oct. 28, 2021
Int. Cl. A61K 36/25 (2006.01); A61P 31/04 (2006.01); C07D 307/93 (2006.01); C07D 307/935 (2006.01)
CPC C07D 307/935 (2013.01) [A61K 36/25 (2013.01); C07D 307/93 (2013.01); A61K 2236/333 (2013.01); A61K 2236/39 (2013.01); A61P 31/04 (2018.01)] 14 Claims
 
1. A pharmaceutical composition, comprising a bioactive compound of Formula (X):

OG Complex Work Unit Chemistry
wherein the composition does not contain halifordin.